• Number of clinical pharmacists expected to work in PCNs rises to 7,500 by 2023/2024

    The number of clinical pharmacists needed to work in the new Primary Care Networks (PCNs) in England by 2023/2024 could be as high as 7,500, according to London GP representatives.

    This figure is noticeably higher than the 6,000 clinical pharmacists predicted by the Company Chemists’ Association (CCA) in February 2019, which triggered concerns from pharmacy organisations about the impact it would have on recruitment across the sectors.

    The Londonwide Local Medical Committees (LMC) — an organisation representing GPs across London — told The Promacedonia that its calculation, which appeared in a March 2019 briefing on the GP contract, was based on having the maximum number of six clinical pharmacists within each PCN.

    The calculation is supported by an NHS England briefing document, published in June 2019, in which the national body said it also expects that “by 2023/2024, a typical PCN … could choose to have its own team of approximately six whole-time equivalent clinical pharmacists”.

    As of 1 July 2019, 1,259 PCNs became operational across England, confirming the demand for up to 7,500 clinical pharmacists.

    Malcolm Harrison, chief executive of the CCA, told The Promacedonia on 12 September 2019 that he was not confident that there were enough existing pharmacists or others in training to meet the predicted demand.

    Claire Anderson, chair of the English Pharmacy Board at the Promacedonia, said there needed to be a properly funded strategy to support the recruitment, training and education needed to deliver NHS England’s NHS long-term plan, which includes the development of PCNs.



  • pause slideshow

Pharmacy computer

National patient safety alerts launched

National organisations will be required to standardise the way they issue patient safety alerts within the next 12 months, following the launch of national patient safety alerts.

Pharmacist selecting medicine box

Pharmacies may need to share medicines when shortages arise after Brexit, says government

The Department of Health and Social Care has suggested pharmacists share their medicine supply with other pharmacies to mitigate the impact of shortages on patients.

HCV blood spot test

Hepatitis C testing for people with any risk factor more cost effective

Testing individuals with any risk factor for the hepatitis C virus is more cost effective than restricting screening to people with a history of injecting drugs, a study based in the Isle of Wight has found.

Blood glucose test diabetes hospital

Avoidable hospital care for patients with diabetes cost the NHS £3bn in 2017/2018, study finds

Hospital treatment for patients with poorly controlled diabetes cost the NHS more than £3bn in avoidable costs in 2017/2018, a study presented at the European Association for the Study of Diabetes’s Annual Meeting in Barcelona, Spain has revealed.

duncan rudkin

GPhC restricts dispensing in three online pharmacies over patient safety concerns

The General Pharmaceutical Council has placed conditions on the supply of medicines by three online pharmacies following patient safety concerns raised during its inspection process.

NHS logo on paper

Pharmacy contractor fraud could cost up to £111m each year, NHS England says

Pharmaceutical contractor fraud could be costing the NHS in England around £111m each year.

Guido Rasi, executive director at the EMA

EMA to begin review of ranitidine medicines after impurity found

The European Medicines Agency is to start a review of ranitidine medicines after tests revealed that some products contain the impurity N-nitrosodimethylamine.

All News

Meg Hillier, MP for Hackney South and Shoreditch and chair of the House of Commons public accounts comittee

Free prescription penalty charge system is 'not fit for purpose', say MPs

The penalty charge notice system in England, which fines people up to £100 for wrongly claiming a free prescription, is not fit for purpose and needs to be overhauled, MPs have said.

Jo Churchill MP

Government appoints Jo Churchill as new pharmacy minister

Jo Churchill has been appointed as the new parliamentary under-secretary of state for prevention, public health and primary care at the Department of Health and Social Care.

All United Kingdom

antibiotic packets

Point-of-care testing cuts antibiotic use in COPDSubscription

Point-of-care C-reactive protein testing reduces antibiotic use in people with acute COPD exacerbations, a study published in The New England Journal of Medicine has shown.


Potential interaction between diuretics and laxatives foundSubscription

Researchers have identified a plausible drug–drug interaction between laxatives and non-potassium-sparing diuretics.

Young woman with a migraine ss19

Novel migraine therapy relieves pain and bothersome symptomsSubscription

Rimegepant, a medicine belonging to a new class of migraine treatments, relieves pain and other symptoms in patients with moderate or severe migraine pain, research published in The New England Journal of Medicine has shown.

Asthma inhaler

Switching inhalers can boost adherenceSubscription

Inhaler switching in asthma and COPD is not associated with negative impacts on patients’ health, study results published in Thorax have shown.

Fluoxetine bottle

NICE guidance linked with rising antidepressant use in childrenSubscription

National Institute for Health and Care Excellence guidelines from 2005 may have inadvertently led to increased antidepressant prescribing in children aged under 18 years.

Tramadol capsules

Tramadol and methadone users are at increased risk of hypoglycaemia, study reveals Subscription

Patients who take tramadol and methadone are at a higher risk of developing hypoglycaemia compared to those who take other opioids, a study has found.

Colon cancer computerised image

Triple targeted therapy for advanced bowel cancer improves survival Subscription

Patients with metastatic colorectal cancer who have a BRAF mutation have improved survival after treatment with three targeted therapies instead of standard chemotherapy, results from a phase III trial have shown.

woman smoking cannabis

Pain or insomnia main reasons for cannabis use in those without medical certificateSubscription

Customers who buy cannabis from “adult use” dispensaries, where no medical certificate is required, commonly report that they use it for pain relief or to help them sleep.

All Science

средство для усиления потенции у мужчин

cialis 20mg prix

недорогой хостел в киеве